The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy

Clinical trial NCT01710332 · COMPLETED

Trial details

NCT number: NCT01710332
Sponsor: Wills Eye
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Central Serous Chorioretinopathy

Start date: 2012-10-01
Primary completion: 2013-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.